Konstantin Konstantinov Codiak Bio Sciences, Inc. (CDAK) insider trading activity

Konstantin Konstantinov is Chief Technology Officer of Codiak BioSciences, Inc.. Currently has a direct ownership of 0 shares of CDAK, which is worth approximately $0. The most recent transaction as insider was on Mar 28, 2023, when has been sold 9,364 shares (Common Stock) at a price of $0.2 per share, resulting in proceeds of $1,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Konstantin Konstantinov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 28 2023	SELL Open market or private sale	$1,872 $0.2 p/Share	9,364 Reduced 100.0%	0 Common Stock
Feb 17 2023	SELL Open market or private sale	$820 $0.59 p/Share	1,391 Reduced 15.77%	7,432 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	4,200 Added 32.25%	8,823 Common Stock
Jan 20 2023	SELL Open market or private sale	$620 $0.58 p/Share	1,069 Reduced 38.18%	1,731 Common Stock
Jan 19 2023	BUY Exercise of conversion of derivative security	-	2,800 Added 50.0%	2,800 Common Stock
Aug 17 2022	SELL Open market or private sale	$2,890 $2.21 p/Share	1,308 Reduced 22.05%	4,623 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	4,200 Added 41.46%	5,931 Common Stock
Jun 08 2021	SELL Open market or private sale	$187,648 $25.79 p/Share	7,276 Reduced 100.0%	0 Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$23,938 $3.29 p/Share	7,276 Added 50.0%	7,276 Common Stock

Also insider at

RGEN

REPLIGEN CORP Healthcare